Literature DB >> 26860863

Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.

Mohamed Essameldin Abdelgawad1,2, Jean-Marie Delaisse3, Maja Hinge1,4, Pia Rosgaard Jensen1, Ragad Walid Alnaimi1, Lars Rolighed5, Lars H Engelholm6, Niels Marcussen7, Thomas Levin Andersen8.   

Abstract

The mechanism coupling bone resorption and formation is a burning question that remains incompletely answered through the current investigations on osteoclasts and osteoblasts. An attractive hypothesis is that the reversal cells are likely mediators of this coupling. Their nature is a big matter of debate. The present study performed on human cancellous bone is the first one combining in situ hybridization and immunohistochemistry to demonstrate their osteoblastic nature. It shows that the Runx2 and CD56 immunoreactive reversal cells appear to take up TRAcP released by neighboring osteoclasts. Earlier preclinical studies indicate that reversal cells degrade the organic matrix left behind by the osteoclasts and that this degradation is crucial for the initiation of the subsequent bone formation. To our knowledge, this study is the first addressing these catabolic activities in adult human bone through electron microscopy and analysis of molecular markers. Periosteoclastic reversal cells show direct contacts with the osteoclasts and with the demineralized resorption debris. These early reversal cells show (1) ¾-collagen fragments typically generated by extracellular collagenases of the MMP family, (2) MMP-13 (collagenase-3) and (3) the endocytic collagen receptor uPARAP/Endo180. The prevalence of these markers was lower in the later reversal cells, which are located near the osteoid surfaces and morphologically resemble mature bone-forming osteoblasts. In conclusion, this study demonstrates that reversal cells colonizing bone surfaces right after resorption are osteoblast-lineage cells, and extends to adult human bone remodeling their role in rendering eroded surfaces osteogenic.

Entities:  

Keywords:  Catabolism; Collagenolysis; Interaction; Osteoblast; Osteoclast; Reversal cells; Reversal phase

Mesh:

Year:  2016        PMID: 26860863     DOI: 10.1007/s00418-016-1414-y

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  56 in total

1.  Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.

Authors:  M T K Mulari; Q Qu; P L Härkönen; H K Väänänen
Journal:  Calcif Tissue Int       Date:  2004-09       Impact factor: 4.333

2.  A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differently.

Authors:  Pia Rosgaard Jensen; Thomas Levin Andersen; Brenda L Pennypacker; Le T Duong; Lars H Engelholm; Jean-Marie Delaissé
Journal:  Biochem Biophys Res Commun       Date:  2013-12-12       Impact factor: 3.575

3.  Steering the osteoclast through the demineralization-collagenolysis balance.

Authors:  Kent Søe; Ditte Marie Horslev Merrild; Jean-Marie Delaissé
Journal:  Bone       Date:  2013-06-15       Impact factor: 4.398

Review 4.  Osteoclast-derived coupling factors in bone remodeling.

Authors:  Kim Henriksen; Morten A Karsdal; T John Martin
Journal:  Calcif Tissue Int       Date:  2013-05-23       Impact factor: 4.333

5.  Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.

Authors:  Chen Zhao; Naoko Irie; Yasunari Takada; Kouji Shimoda; Takeshi Miyamoto; Toru Nishiwaki; Toshio Suda; Koichi Matsuo
Journal:  Cell Metab       Date:  2006-08       Impact factor: 27.287

6.  Correlation between absence of bone remodeling compartment canopies, reversal phase arrest, and deficient bone formation in post-menopausal osteoporosis.

Authors:  Thomas L Andersen; Ellen M Hauge; Lars Rolighed; Jens Bollerslev; Per Kjærsgaard-Andersen; Jean-Marie Delaisse
Journal:  Am J Pathol       Date:  2014-02-05       Impact factor: 4.307

7.  Mechanisms of osteoclast-dependent bone formation.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2013-12-04

8.  The non-phagocytic route of collagen uptake: a distinct degradation pathway.

Authors:  Daniel H Madsen; Signe Ingvarsen; Henrik J Jürgensen; Maria C Melander; Lars Kjøller; Amanda Moyer; Christian Honoré; Charlotte A Madsen; Peter Garred; Sven Burgdorf; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

9.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

Authors:  S Detre; G Saclani Jotti; M Dowsett
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

10.  A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.

Authors:  Thomas L Andersen; Maria del Carmen Ovejero; Tove Kirkegaard; Thomas Lenhard; Niels T Foged; Jean-Marie Delaissé
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

View more
  17 in total

1.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2017-03-01       Impact factor: 4.304

Review 2.  Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion.

Authors:  Riko Kitazawa; Ryuma Haraguchi; Mana Fukushima; Sohei Kitazawa
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

Review 3.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

4.  Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis.

Authors:  Fumitaka Hirano; Kayoko Furukawa Okuma; Yukichi Zenke; Kunitaka Menuki; Hideo Ohnishi; Fumio Fukuda; Akinori Sakai; Noriaki Yamamoto; Taketoshi Shimakura; Hiroshige Sano; Yuta Tokunaga; Hideaki E Takahashi
Journal:  Bone Rep       Date:  2021-05-07

5.  Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats.

Authors:  Hao Wu; Qingxiang Zhong; Jing Wang; Man Wang; Fang Fang; Zhi Xia; Rongling Zhong; Houcai Huang; Zhongcheng Ke; Yingjie Wei; Liang Feng; Ziqi Shi; E Sun; Jie Song; Xiaobin Jia
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

6.  Inhibition of cathepsin K promotes osseointegration of titanium implants in ovariectomised rats.

Authors:  Chun Yi; Ke-Yi Hao; Ting Ma; Ye Lin; Xi-Yuan Ge; Yu Zhang
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

7.  KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment.

Authors:  Li Chen; Kaikai Shi; Thomas Levin Andersen; Weimin Qiu; Moustapha Kassem
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

8.  NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue.

Authors:  Angélica Rivera-Villaseñor; Frida Higinio-Rodríguez; Laura Nava-Gómez; Bárbara Vázquez-Prieto; Isnarhazni Calero-Vargas; Rafael Olivares-Moreno; Mónica López-Hidalgo
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

9.  Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.

Authors:  Andre J van Wijnen; Abbas Jafari; Michaela R Reagan; Heather Fairfield; Amel Dudakovic; Casper M Khatib; Mariah Farrell; Samantha Costa; Carolyne Falank; Maja Hinge; Connor S Murphy; Victoria DeMambro; Jessica A Pettitt; Christine W Lary; Heather E Driscoll; Michelle M McDonald; Moustapha Kassem; Clifford Rosen; Thomas L Andersen
Journal:  Cancer Res       Date:  2020-11-20       Impact factor: 13.312

10.  Bone Canopies in Pediatric Renal Osteodystrophy.

Authors:  Renata C Pereira; Thomas L Andersen; Peter A Friedman; Navdeep Tumber; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.